Discover undervalued stocks with Eulerpool.

Subscribe for $2

Ingevity Stock NGVT

Price

0
Today +/-
-0
Today %
-0 %

Ingevity stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Ingevity stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Ingevity stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Ingevity stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Ingevity's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Ingevity Stock Price History

DateIngevity Price
9/19/20250 undefined
9/19/202555.97 undefined
9/18/202557.78 undefined
9/17/202556.68 undefined
9/16/202556.30 undefined
9/15/202558.71 undefined
9/12/202558.17 undefined
9/11/202558.76 undefined
9/10/202557.50 undefined
9/9/202558.72 undefined
9/8/202560.76 undefined
9/5/202559.79 undefined
9/4/202558.90 undefined
9/3/202557.82 undefined
9/2/202558.29 undefined
8/29/202558.40 undefined
8/28/202557.97 undefined
8/27/202557.42 undefined
8/26/202556.87 undefined
8/25/202557.00 undefined

Ingevity Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Ingevity, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Ingevity from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Ingevity’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Ingevity. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Ingevity’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Ingevity’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Ingevity’s growth potential.

Ingevity Revenue, EBIT and net profit per share

DateIngevity RevenueIngevity EBITIngevity Net Income
2027e1.42 B undefined353.6 M undefined211.31 M undefined
2026e1.37 B undefined318.58 M undefined181.45 M undefined
2025e1.32 B undefined298.52 M undefined164.13 M undefined
20241.41 B undefined263.2 M undefined-430.3 M undefined
20231.69 B undefined255.6 M undefined-5.4 M undefined
20221.67 B undefined345 M undefined211.6 M undefined
20211.39 B undefined315.2 M undefined118.1 M undefined
20201.22 B undefined292.2 M undefined181.4 M undefined
20191.29 B undefined303.1 M undefined183.7 M undefined
20181.13 B undefined262.9 M undefined169.1 M undefined
2017972.4 M undefined202.2 M undefined126.5 M undefined
2016908.3 M undefined163.6 M undefined35.2 M undefined
2015958.3 M undefined166.3 M undefined79.7 M undefined
20141.04 B undefined211 M undefined129 M undefined
2013980 M undefined192 M undefined119 M undefined
2012939 M undefined202 M undefined119 M undefined

Ingevity Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
20122013201420152016201720182019202020212022202320242025e2026e2027e
0.940.981.040.960.910.971.131.291.221.391.671.691.411.321.371.42
-4.376.22-7.97-5.227.0516.5614.03-5.8814.3919.911.44-16.90-6.403.953.51
31.6330.1031.0328.7130.1833.8536.7237.3138.2436.8134.1727.8432.2934.5033.1932.06
297295323275274329416482465512570471454000
1191191297935126169183181118211-5-430164181211
--8.40-38.76-55.70260.0034.138.28-1.09-34.8178.81-102.378,500.00-138.1410.3716.57
42424242.142.342.542.642.241.540.138.536.536.32000
- - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Ingevity Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Ingevity is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (k)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
201320142015201620172018201920202021202220232024
                       
12203230.587.977.556.5257.7275.476.795.968
10710895.289.8100124156.2153.7167231.2193.2147.5
0712.416.310.618.419.11324.418.117.824.5
103130148.9151.2160191.4212.5189241.2335308.8226.8
667.87.410.211.418.915.316.91842.926.4
228271296.3295.2368.7422.7463.2628.7724.9679658.6493.2
326410437.5422.8438.5523.8719.3753.5772.4855.3829.4709.3
0000000035.3109.899.287.3
000000000000
161320.718.123.4140.7418.7397.3378.7455.8385.3323.9
131311.912.412.4130.7436.4445.3442518.5527.5175.2
101112.384.386.697.3104.1109.7115.7118.1123.3233.7
0.370.450.480.540.560.891.681.711.742.061.961.53
0.590.720.780.830.931.322.142.332.472.742.622.02
                       
000400400400400400400400400400
00016140.198.3112.8121.3136.3153164.9176.8
0000.130.140.310.50.680.81.0110.57
326417513.6-19-11.7-17.7-54.713.1-46.8-26.7-41.4
000000000000
0.330.420.510.130.270.390.610.80.951.111.140.71
729664.879.283.192.999.1104.2125.8174.8158.494.5
243023.339.156.471.776.180.6108116.393.892.4
10102.311.14.37.517.812.615.511.526.315.9
000000000000
039.47.59.411.222.52619.60.984.461.3
10613999.8136.9153.2183.3215.5223.4268.9303.5362.9264.1
0.090.090.080.480.440.741.231.271.251.471.381.34
63697570.543.341.5112130.4130.111986.472.1
1046.59.511.210.55571.2146.2143.2159.8151.5
0.160.160.160.560.50.791.41.471.531.731.631.56
0.270.30.260.70.650.981.611.691.82.041.991.83
0.590.720.770.830.921.372.222.52.743.153.132.54
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Ingevity provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Ingevity's financial health and stability.

Assets

Ingevity's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Ingevity must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Ingevity after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Ingevity's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
201220132014201520162017201820192020202120222023
1221181338444145181183181118211-5
3233333438405785100109108122
2328-7-2501416-4-5-44
-31-28-26-524-10-18-358-63-66-155
1111-2523443395414580298
07761516264839475482
00012261341446535429
12613714372127174252275352293313205
-40-63-101-100-56-52-93-114-82-103-142-109
-47-64-102-89-126-58-414-658-110-140-553-77
-7-1-111-69-6-320-543-28-36-41132
000000000000
-6031402-3630338548-26199-7
00000-6-47-6-88-109-145-92
-77-79-3127-3-57153369-50-13348-99
-71-79-3425-405-14-102-10-102-50
000000000000
4-4812-157-10-1319317-19827
867442-28.771.2121.7158.1160.9270.3189.2170.695.3
000000000000

Ingevity stock margins

The Ingevity margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ingevity. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ingevity.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Ingevity's sales revenue. A higher gross margin percentage indicates that the Ingevity retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Ingevity's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Ingevity's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Ingevity's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Ingevity. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Ingevity's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Ingevity Margin History

Ingevity Gross marginIngevity Profit marginIngevity EBIT marginIngevity Profit margin
2027e32.33 %24.95 %14.91 %
2026e32.33 %23.29 %13.26 %
2025e32.33 %22.68 %12.47 %
202432.33 %18.71 %-30.6 %
202327.89 %15.11 %-0.32 %
202234.17 %20.68 %12.68 %
202136.85 %22.65 %8.49 %
202038.28 %24.03 %14.92 %
201937.28 %23.44 %14.21 %
201836.77 %23.19 %14.92 %
201733.83 %20.79 %13.01 %
201630.21 %18.01 %3.88 %
201528.74 %17.35 %8.32 %
201431.03 %20.27 %12.39 %
201330.1 %19.59 %12.14 %
201231.63 %21.51 %12.67 %

Ingevity Stock Sales Revenue, EBIT, Earnings per Share

The Ingevity earnings per share therefore indicates how much revenue Ingevity has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Ingevity earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Ingevity's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Ingevity’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ingevity's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Ingevity Revenue, EBIT and net profit per share

DateIngevity Sales per ShareIngevity EBIT per shareIngevity Earnings per Share
2027e39.01 undefined0 undefined5.82 undefined
2026e37.66 undefined0 undefined5 undefined
2025e36.23 undefined0 undefined4.52 undefined
202438.72 undefined7.25 undefined-11.85 undefined
202346.36 undefined7 undefined-0.15 undefined
202243.33 undefined8.96 undefined5.5 undefined
202134.7 undefined7.86 undefined2.95 undefined
202029.3 undefined7.04 undefined4.37 undefined
201930.64 undefined7.18 undefined4.35 undefined
201826.61 undefined6.17 undefined3.97 undefined
201722.88 undefined4.76 undefined2.98 undefined
201621.47 undefined3.87 undefined0.83 undefined
201522.76 undefined3.95 undefined1.89 undefined
201424.79 undefined5.02 undefined3.07 undefined
201323.33 undefined4.57 undefined2.83 undefined
201222.36 undefined4.81 undefined2.83 undefined

Ingevity business model

Ingevity Corp was founded in 1946 by Dr. Howard E. Baughman and is headquartered in North Charleston, South Carolina. The company is a global enterprise specializing in various types of machinery, vehicle, energy, and environmental technologies. The business model of Ingevity Corp is to develop products that help reduce environmental pollution and improve the performance of machines and vehicles. The company offers a wide range of solutions for various applications and works closely with customers from different industries to find individual solutions. Ingevity Corp operates in three business segments: Performance Chemicals, Performance Materials, and High Purity Fluids. The Performance Chemicals business segment offers a wide range of solutions for air and water filtration, fuel and oil processing, chemical intermediates, and construction chemicals. The air purification products of Ingevity Corp are used in many different industries, including automotive, aviation, construction, and food manufacturing. The Performance Materials business segment provides solutions for the production of polymers, composites, paints and coatings, as well as asphalt and concrete additives. Ingevity Corp's products improve the durability, strength, and surface quality of many materials used in various industries. The High Purity Fluids business segment produces high-purity liquids for electronic applications. These fluids are used in the semiconductor and electronics industry to avoid contamination and improve the performance of electronic devices. Some of the products manufactured by Ingevity Corp include activated carbon for reducing air and water pollution, resins and additives that improve the performance of fuels and oils, as well as fluids and chemicals for electronics and semiconductor manufacturing. Ingevity Corp has a long history of innovation and has been recognized for its achievements in the environmental and technology industry. In 2018, the company was honored by Fortune as one of the world's most admired companies. Overall, Ingevity Corp is a leading company in the environmental and technology industry that focuses on developing environmentally friendly solutions to improve the performance of machines and vehicles. With its three business segments and wide range of products, it is well positioned to meet the needs of its customers and continue to grow and innovate. Ingevity is one of the most popular companies on Eulerpool.com.

Ingevity SWOT Analysis

Strengths

Ingevity Corp benefits from the following strengths:

  • Strong product portfolio in specialty chemicals segment.
  • Robust research and development capabilities.
  • Well-established partnerships with key industry players.
  • Strong brand reputation and customer loyalty.

Weaknesses

Ingevity Corp faces the following weaknesses:

  • Dependency on a limited number of suppliers.
  • Relatively high production costs impacting profitability.
  • Market vulnerability to global economic fluctuations.
  • Limited geographical presence compared to competitors.

Opportunities

Ingevity Corp can explore the following opportunities:

  • Increasing demand for environmentally friendly chemicals.
  • Growth potential in emerging markets.
  • Expansion through strategic acquisitions or partnerships.
  • Development of innovative products for emerging industries.

Threats

Ingevity Corp should be wary of the following threats:

  • Intense competition from existing and new players.
  • Increasing regulations and compliance requirements.
  • Fluctuating raw material prices impacting profit margins.
  • Potential disruptions in supply chain and logistics.

Ingevity Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Ingevity Revenue by Segment

Segmente20232022202120202019201820172016
Industrial Specialties product line532.3 M USD633.8 M USD493.5 M USD316 M USD385.5 M USD440.5 M USD--
Automotive Technologies product line---477.7 M USD454.9 M USD362 M USD--
Pavement Technologies product line-241.3 M USD195.4 M USD186.8 M USD111.4 M USD---
Engineered Polymers product line-244.7 M USD185.8 M USD127.7 M USD122.1 M USD---
Oilfield Technologies product line---75.6 M USD183.3 M USD114.2 M USD--
Road Technologies product line369.8 M USD-------
Process Purification product line---32.3 M USD35.7 M USD38.4 M USD--

  • 3 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Ingevity Revenue by Segment

Segmente20232022202120202019201820172016
Performance Materials586 M USD548.5 M USD516.8 M USD-----

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Ingevity Revenue by Segment

Segmente20232022202120202019201820172016
Performance Chemicals---706.1 M USD802.3 M USD733.2 M USD623.1 M USD607.3 M USD
Performance Chemicals segment902.1 M USD1.12 B USD874.7 M USD-----
Performance Materials---510 M USD490.6 M USD400.4 M USD349.3 M USD301 M USD
Advanced Polymer Technologies segment204 M USD-------

Ingevity Revenue by Region

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Ingevity Revenue by Segment

DateAsia PacificEurope, Middle East and AfricaEurope, Middle East, and AfricaNorth AmericaSouth America
2023364 M USD-215.5 M USD1.07 B USD43.1 M USD
2022398.7 M USD-242.2 M USD983.2 M USD44.2 M USD
2021385.5 M USD-219.6 M USD763.3 M USD23.1 M USD
2020345.4 M USD-174.9 M USD676.9 M USD18.9 M USD
2019281.4 M USD-193.6 M USD795.7 M USD22.2 M USD
2018171.4 M USD169.9 M USD-770.4 M USD21.9 M USD
2017142.5 M USD149.2 M USD-662.9 M USD17.8 M USD
2016138.8 M USD151.1 M USD-597.8 M USD20.6 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Ingevity Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Ingevity historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Ingevity shares outstanding

The number of shares was Ingevity in 2024 — This indicates how many shares 36.323 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Ingevity earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Ingevity's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Ingevity’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ingevity's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Ingevity.

Ingevity latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20251.19 1.39  (17.22 %)2025 Q2
3/31/20250.75 0.99  (31.6 %)2025 Q1
12/31/20240.31 0.95  (202.84 %)2024 Q4
9/30/20240.92 1.1  (19.83 %)2024 Q3
6/30/20241.08 1.01  (-6.06 %)2024 Q2
3/31/20240.33 0.52  (59.31 %)2024 Q1
12/31/2023-0.19 0.21  (208.36 %)2023 Q4
9/30/20231.24 1.21  (-2.36 %)2023 Q3
6/30/20231.4 1.41  (0.69 %)2023 Q2
3/31/20231.15 1.09  (-5.55 %)2023 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Ingevity stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

77

👫 Social

87

🏛️ Governance

91

Environment

Scope 1 - Direct Emissions
241,299.9
Scope 2 - Indirect emissions from purchased energy
139,613.4
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
380,913.3
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees24
Percentage of women in management
Percentage of Asian employees
Share of Asian management1.9
Percentage of Hispanic/Latino employees
Hispano/Latino Management share3.3
Percentage of Black employees
Black Management Share6.7
Percentage of white employees
White Management Share85.6
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Ingevity shareholders

%
Name
Stocks
Change
Date
14.42378 % BlackRock Institutional Trust Company, N.A.5,239,150-68,0436/30/2025
11.25116 % The Vanguard Group, Inc.4,086,75910,9946/30/2025
6.00768 % Wellington Management Company, LLP2,182,170-117,1426/30/2025
4.70025 % American Century Investment Management, Inc.1,707,273230,5256/30/2025
4.12437 % State Street Global Advisors (US)1,498,094-49,5676/30/2025
3.53278 % Segall Bryant & Hamill, LLC1,283,2103,9486/30/2025
3.43707 % Thrivent Asset Management, LLC1,248,447-134,60612/31/2024
3.23201 % Millennium Management LLC1,173,962-52,2276/30/2025
3.02662 % Royce Investment Partners1,099,359-109,0866/30/2025
2.55715 % Brown Advisory928,835-9,9856/30/2025
1
2
3
4
5
...
10

Ingevity Executives and Management Board

Mr. Richard White

(61)
Ingevity Senior Vice President - Performance Chemicals, and President, Industrial Specialties and Pavement Technologies
Compensation 2.27 M

Ms. Mary Hall

(67)
Ingevity Chief Financial Officer, Executive Vice President, Treasurer
Compensation 1.68 M

Mr. S. Edward Woodcock

(58)
Ingevity Executive Vice President and President - Performance Materials (since 2015)
Compensation 1.56 M

Ms. Jean Blackwell

(70)
Ingevity Independent Chairman of the Board (since 2021)
Compensation 308,012

Mr. Bruce Hoechner

(64)
Ingevity Independent Director
Compensation 237,597
1
2
3
4

Ingevity Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
BorgWarner Stock
BorgWarner
SupplierCustomer0,870,610,740,860,840,82
Univar Solutions Stock
Univar Solutions
SupplierCustomer0,830,910,28-0,47-0,630,42
WestRock Stock
WestRock
SupplierCustomer0,820,43-0,13-0,170,570,84
HB Fuller Stock
HB Fuller
SupplierCustomer0,810,830,460,86-0,050,64
Solvay Stock
Solvay
SupplierCustomer0,810,170,690,590,770,88
PPG Industries Stock
PPG Industries
SupplierCustomer0,790,310,530,810,840,89
Halliburton Stock
Halliburton
SupplierCustomer0,710,74-0,44-0,86-0,830,23
Huntsman Stock
Huntsman
SupplierCustomer0,690,790,77-0,38-0,730,33
Marathon Oil Stock
Marathon Oil
SupplierCustomer0,670,76-0,45-0,84-0,860,24
Ecolab Stock
Ecolab
SupplierCustomer0,600,710,460,910,780,63
1
2

Most common questions regarding Ingevity

What values and corporate philosophy does Ingevity represent?

Ingevity Corp represents a strong commitment to sustainable practices and innovative solutions. The company focuses on three key values: Integrity, Innovation, and Collaboration. Ingevity is dedicated to conducting business with honesty and transparency, always adhering to the highest ethical standards. With a focus on continuous improvement and strategic investments in research and development, Ingevity strives to deliver innovative and sustainable solutions to its customers. Moreover, the company believes in the power of collaboration and partnerships to drive growth and create long-term value. Overall, Ingevity Corp is dedicated to making a positive impact on its stakeholders, the environment, and the communities it serves.

In which countries and regions is Ingevity primarily present?

Ingevity Corp is primarily present in the United States.

What significant milestones has the company Ingevity achieved?

Ingevity Corp has achieved several significant milestones in its history. Firstly, the company was spun off from WestRock Company in 2016, establishing itself as an independent entity. In 2017, Ingevity completed the acquisition of Georgia-Pacific's pine chemicals business, expanding its product portfolio and market presence. Additionally, in 2019, Ingevity acquired the Capa™ caprolactone division from Perstorp, enhancing its offerings in specialty chemicals. These strategic moves have propelled Ingevity Corp's growth and solidified its position as a leading provider of specialty chemicals and materials.

What is the history and background of the company Ingevity?

Ingevity Corp has a rich history and background in the chemical industry. The company was founded in 2016 and is headquartered in North Charleston, South Carolina. Ingevity Corp specializes in developing and manufacturing specialty chemicals and carbon materials that are used in a wide range of industries. With a focus on sustainability and innovation, Ingevity Corp continues to grow and expand its product offerings. The company has a strong global presence, serving customers in more than 100 countries. Ingevity Corp strives to deliver high-quality solutions and enhance the performance of various products, making it a key player in the chemical market.

Who are the main competitors of Ingevity in the market?

The main competitors of Ingevity Corp in the market are Calgon Carbon Corporation, Cabot Corporation, and Kuraray Co., Ltd.

In which industries is Ingevity primarily active?

Ingevity Corp is primarily active in the chemical industry.

What is the business model of Ingevity?

The business model of Ingevity Corp revolves around supplying specialty chemicals and high-performance carbon materials. As a leading global provider, Ingevity focuses on addressing crucial environmental, energy, and purification challenges through innovative solutions. With a diverse portfolio, the company serves various sectors including automotive, construction, energy, and industrial markets. Ingevity Corporation leverages its advanced technologies and expertise to enhance the performance, efficiency, and sustainability of its customers' products. By consistently delivering exceptional value and sustainable solutions, Ingevity Corp has established itself as a trusted partner in the specialty chemicals industry.

What is the P/E ratio of Ingevity 2025?

The P/E ratio cannot be calculated for Ingevity at the moment.

What is the P/S ratio of Ingevity 2025?

The P/S cannot be calculated for Ingevity currently.

What is the Quality Investing of Ingevity?

The Quality Investing for Ingevity is 1/10.

What is the revenue of Ingevity 2025?

The expected Ingevity revenue is 1.32 B USD.

How high is the profit of Ingevity 2025?

The expected Ingevity profit is 164.13 M USD.

What is the business model of Ingevity

Ingevity Corp is a leading company in the production of specialty materials and chemicals that focuses on providing solutions for a more sustainable future. The company is based in North Charleston, South Carolina, USA, and has branches in various parts of the world. The company's core business consists of three main divisions: Performance Materials, Specialty Chemicals, and Carbon Materials. The Performance Materials division focuses on the production of materials used in various applications such as automotive, aerospace, construction, electronics, and energy industries. The Specialty Chemicals division produces high-quality chemicals and substances used in agriculture, food and beverage, construction and coating, and pharmaceutical industries. The Carbon Materials division focuses on the production of carbon products used in the aerospace industry, automotive industry, wind turbine construction, and electronics industry. Ingevity Corp also offers a wide range of products marketed under its Adsorbents brand, including bio-based resins, activated carbon, and other adsorbents used in various applications such as emission control in the automotive industry or water purification. The company also has a strong presence in the oil and gas products market, where it uses its adsorbents and other specialty products to assist in the production and transportation of energy resources. Ingevity Corp is committed to innovation and sustainability and aims to develop products that contribute to environmental protection. The company has developed a number of sustainability and corporate social responsibility initiatives, such as the use of renewable energy sources, reducing energy consumption, transitioning to bio-based raw materials, and innovations that help reduce CO2 footprint. The company also aims to expand its global presence through partnerships and acquisitions to strengthen its position as a leading provider of specialty materials and chemicals in the market. Overall, Ingevity Corp's business model is focused on offering high-quality and innovative products and services that contribute to shaping a more sustainable future while ensuring profitable growth.

What is the Ingevity dividend?

Ingevity pays a dividend of 0 USD distributed over payouts per year.

How often does Ingevity pay dividends?

The dividend cannot currently be calculated for Ingevity or the company does not pay out a dividend.

What is the Ingevity ISIN?

The ISIN of Ingevity is US45688C1071.

What is the Ingevity WKN?

The WKN of Ingevity is A2AHZS.

What is the Ingevity ticker?

The ticker of Ingevity is NGVT.

How much dividend does Ingevity pay?

Over the past 12 months, Ingevity paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ingevity is expected to pay a dividend of 0 USD.

What is the dividend yield of Ingevity?

The current dividend yield of Ingevity is .

When does Ingevity pay dividends?

Ingevity pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ingevity?

Ingevity paid dividends every year for the past 0 years.

What is the dividend of Ingevity?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ingevity located?

Ingevity is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Ingevity kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ingevity from 9/22/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2025.

When did Ingevity pay the last dividend?

The last dividend was paid out on 9/22/2025.

What was the dividend of Ingevity in the year 2024?

In the year 2024, Ingevity distributed 0 USD as dividends.

In which currency does Ingevity pay out the dividend?

The dividends of Ingevity are distributed in USD.

All fundamentals about Ingevity

Our stock analysis for Ingevity Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ingevity Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.